Ove B Schaffalitzky de Muckadell
Overview
Explore the profile of Ove B Schaffalitzky de Muckadell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
807
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hansen F, Ploug M, Jorgensen G, Karstensen J, de Muckadell O, Laursen S
Ugeskr Laeger
. 2024 Sep;
186(35).
PMID: 39234896
This review evaluates the evidence for the use of over-the-scope clips (OTSC), topical haemostatic agents (THA), and prophylactic embolisation (PE) in patients with peptic ulcer bleeding (PUB). The use of...
2.
Granholm A, Moller M, Gluud C, Lundh A, Hrobjartsson A, de Muckadell O, et al.
Ugeskr Laeger
. 2023 Nov;
185(45).
PMID: 37987450
The randomised clinical trial is the most reliable study design to compare the effects of different interventions, however, the methodological quality of randomised clinical trials varies. In this review, the...
3.
Nielsen M, de Muckadell O, Laursen S
J Clin Med
. 2023 Nov;
12(21).
PMID: 37959188
Background: Endoscopic treatment guided by Doppler endoscopic probes (DEPs) during index endoscopy may be associated with improved outcome in patients with peptic ulcer bleeding (PUB). As competencies for DEP evaluation...
4.
Hedegaard C, Soerensen M, Helskov Jorgensen L, de Muckadell O
Scand J Clin Lab Invest
. 2022 Sep;
82(5):371-377.
PMID: 36062589
Hypozincemia is a well-known phenomenon in patients with infection caused by the activation of the acute phase response (APR). Zn status is still based upon plasma Zn levels in venous...
5.
Laursen S, Stanley A, Laine L, de Muckadell O
Scand J Gastroenterol
. 2022 Jul;
57(12):1423-1429.
PMID: 35853234
Background: Rebleeding is a frequent complication of peptic ulcer bleeding (PUB). The associated prognosis remains rather unclear because previous studies generally also included non-ulcer lesions. Objective: We aimed to identify...
6.
Jorgensen L, Sorensen M, Lauridsen M, Rasmussen L, Alfiler R, Iversen V, et al.
Scand J Clin Lab Invest
. 2022 Jun;
82(4):261-266.
PMID: 35758940
We have established and describe two measurement procedures to diagnose possible zinc (Zn) deficiency; albumin-corrected Zn concentration and available free Zn-binding capacity. Reference intervals for both biomarkers were established in...
7.
Tan M, Brusgaard K, Gerdes A, Larsen M, Mortensen M, Detlefsen S, et al.
Ann Hum Genet
. 2022 Mar;
86(4):195-206.
PMID: 35312039
No abstract available.
8.
Tan M, Brusgaard K, Gerdes A, Mortensen M, Detlefsen S, de Muckadell O, et al.
Clin Genet
. 2021 Jul;
100(5):551-562.
PMID: 34313325
First-degree relatives (FDRs) of familial pancreatic cancer (FPC) patients have increased risk of developing pancreatic ductal adenocarcinoma (PDAC). Investigating and understanding the genetic basis for PDAC susceptibility in FPC predisposed...
9.
Carlsen N, Laursen S, de Muckadell O
Scand J Gastroenterol
. 2021 Jul;
56(9):1011-1016.
PMID: 34282993
Background: Rebleeding is a frequent complication of peptic ulcer bleeding (PUB) and is associated with increased mortality. Blood pressure and heart rate are two easy non-invasive measurements to evaluate the...
10.
Tan M, Brusgaard K, Gerdes A, Mortensen M, Detlefsen S, de Muckadell O, et al.
Scand J Gastroenterol
. 2021 Jun;
56(8):965-971.
PMID: 34165379
Background: Familial Pancreatic Cancer (FPC) is responsible for up to 10% of all cases of pancreatic ductal adenocarcinoma (PDAC). Individuals predisposed for FPC have an estimated lifetime risk of 16-39%...